← Eichor
Study identifier: NCT06887335 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Deep Sedation With Pre-emptive Endotracheal Intubation for Advanced Bronchoscopy Procedures

Condition: Lung Diseases  ·  Sponsor: Pusan National University Yangsan Hospital

PhaseN/A
Planned participants203
Who can joinAll sexes, 19 Years to 90 Years
Healthy volunteersNo

About this study

Bronchoscopy is crucial for diagnosing and treating respiratory diseases and is recommended under sedation. Deep sedation improves patient comfort and procedural efficiency, especially in complex cases, by reducing movement and coughing. However, it carries risks of respiratory depression and airway obstruction, potentially requiring premature termination or urgent intubation. Determining the optimal timing for intubation can be challenging despite proper monitoring. To enhance safety, the investigator has performed bronchoscopy under deep sedation with preemptive intubation for years, sharing this experience with other hospitals. This study aims to evaluate its safety and feasibility through a multicenter prospective observational approach.

This description comes directly from the study's public registry record.

Talk to the study team

Hee Yun Seol, MD, PhD  ·  82-55-360-3854  ·  seolhy@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Pusan National University Yangsan HospitalYangsan, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06887335